What is Medicus Sciences Acquisition Corp. (MSAC) stock price today?

Medicus Sciences Acquisition Corp. (MSAC) is currently trading at $10.17, up 0.1% today.

What is MSAC P/E ratio?

Medicus Sciences Acquisition Corp.'s P/E ratio is 56.50. This is above the market average, reflecting high growth expectations.

What is MSAC return on equity (ROE)?

Medicus Sciences Acquisition Corp.'s return on equity (ROE) is 2.35%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

NASDAQ · Shell Companies

Medicus Sciences Acquisition Corp. (MSAC) Stock

$10.17 +0.10% NASDAQ: MSAC Financial Services

Valuation

Metric	Value
Price	$10.17
Market Cap	$0
P/E Ratio	56.50
P/B Ratio	1.23
P/S Ratio	0.00
EPS (TTM)	$0.18
52-Week High	$10.18
52-Week Low	$9.72
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	2.35%
ROA	2.13%
ROCE	-0.66%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.00
Current Ratio	49.36

Annual Financials (USD)

Metric	2020	2021
Revenue	—	$0
Operating Profit	—	$-1.0M
Net Profit	—	$2.0M
EPS	—	$0.18
Op Margin	—	—

Balance Sheet (USD)

Metric	2020	2021
Total Assets	$0	$94.0M
Total Liabilities	$0	$8.0M
Cash	$0	$1.0M
Borrowings	$0	$0

Cash Flow (USD)

Metric	2020	2021
Operating Cash Flow	—	$-1.0M
Investing Cash Flow	—	$-92.0M
Financing Cash Flow	—	$94.0M
Net Cash Flow	—	$1.0M
Free Cash Flow	$0	$-1.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.20
EV / EBITDA	2.33
FCF Yield	—
Quick Ratio	49.37
Interest Coverage	0.00
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ACAHAtlantic Coastal Acquisition Corp.	$10.45	-1.69%	24.88	$127.05M	0.00%
ADER26 Capital Acquisition Corp.	$11.08	+0.09%	52.76	$114.18M	0.00%
CPTKCrown Proptech Acquisitions	$10.78	+0.75%	-23.96	$119.62M	0.00%
JUNJuniper II Corp.	$10.59	-0.19%	14.92	$129.70M	0.00%
MEOAMinority Equality Opportunities Acquisition Inc.	$26.54	+0.00%	22.49	$113.58M	0.00%

About Medicus Sciences Acquisition Corp.

Medicus Sciences Acquisition Corp., founded in 2020 and headquartered in New York, New York, currently has no substantial independent business activities. Its main goal is to execute a business combination—such as a merger, stock exchange, asset purchase, or reorganization—with one or more enterprises. The company's strategic focus is on the healthcare industry, particularly the medical technology sector, seeking opportunities both domestically in the United States and around the world.

the stock is valued at a price-to-earnings (P/E) ratio of 56.50, price-to-book of 1.23, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $9.72 and $10.18, and currently trades at its 52-week high.

On profitability, Medicus Sciences Acquisition Corp. generates a return on equity (ROE) of 2.35%, return on capital employed of -0.66%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.medicusspac.com